Trump and Xi are negotiating over tariffs, rare earths, technology and supply chains, with the outcome likely to affect economies far beyond the US and China.
FILE PHOTO: US President Donald Trump and Chinese President Xi Jinping react as they hold a bilateral meeting at Gimhae International Airport, on the sidelines of the Asia-Pacific Economic Cooperation (APEC) summit, in Busan, South Korea, October 30, 2025. REUTERS/Evelyn Hockstein/File Photo
US President Donald Trump is hosting Chinese President Xi Jinping in Washington this week for a summit that could influence the next phase of the US-China economic relationship. Trade, tariffs, rare earths, artificial intelligence, technology restrictions, energy and supply chains are all part of the broader negotiations between the world's two largest economies.
For India, the significance of the Trump-Xi meeting goes well beyond the bilateral relationship between Washington and Beijing.
India sits between two competing economic ecosystems. The United States is one of India's biggest export markets and a major source of technology, investment and strategic partnerships. China, meanwhile, remains India's largest source of imports, particularly for electronics, machinery, chemicals and several industrial inputs. India's economic strategy increasingly depends on expanding its exports while reducing excessive dependence on Chinese supply chains.
That creates a complicated equation. If Trump and Xi reach an accommodation, India could benefit from greater stability in global trade and lower supply-chain disruption. But a smoother US-China relationship could also reduce the urgency among American and multinational companies to shift production away from China.
The outcome therefore matters for India in two opposite ways.
The first India advantage: America still needs alternative supply chains
The US-China trade relationship has already pushed American companies and policymakers to reconsider their dependence on China.
The latest US Trade Representative data shows that US goods imports from India reached $103.8 billion in 2025, up 18.9% from 2024. US goods exports to India were $45.6 billion, taking total US goods trade with India to an estimated $149.4 billion.
That gives India an established export relationship at precisely the time Washington is looking to make supply chains more resilient.
The opportunity extends beyond the headline trade numbers. Electronics, engineering goods, pharmaceuticals, chemicals and other manufactured products are areas where India is trying to increase its presence in global supply chains.
India's latest trade data shows that the momentum is already visible. Merchandise exports reached $215.91 billion during April-August 2026-27, up 17.85% year on year. Electronic goods exports increased sharply, with August 2026 exports rising 89.82% to $5.55 billion, according to the Ministry of Commerce and Industry.
If US companies continue diversifying suppliers even after a Trump-Xi accommodation, India has a ready-made opening.
But there is another side: China remains deeply embedded in India
India's dependence on China is much harder to replace quickly. According to India's Department of Commerce, China accounted for $131.62 billion of India's imports in FY2025-26, compared with Indian exports of $19.47 billion.
The import basket explains why this relationship cannot simply be switched off.
India imports large quantities of electronics, electrical and non-electrical machinery, chemicals, plastics, transport equipment, metals and pharmaceutical products from China. Data compiled by the India Brand Equity Foundation shows Chinese imports into India reached about $131.63 billion in FY2025-26, including $49.21 billion of electronic goods and $24.51 billion of machinery.
This means a US-China deal that restores smoother Chinese access to global markets could benefit Indian manufacturers that rely on Chinese components. But it could also make it harder for Indian companies to replace Chinese suppliers in areas where China enjoys significant cost and scale advantages.
The India story is therefore not simply about replacing China. It is about reducing vulnerability while using Chinese inputs where they remain commercially necessary.
Rare earths: India's biggest strategic warning
Rare earths provide perhaps the clearest example of why the Trump-Xi negotiations matter to India.
China dominates global rare-earth mining and, even more significantly, processing and refining. Reuters reported this week that China controls up to 70% of global rare-earth mining and more than 85% of refining and production of rare-earth metals.
The issue has already become a bargaining chip between Washington and Beijing. Reuters reported that rare-earth flows to US companies remain a concern despite increased shipments from China, with firms in sensitive industries still facing difficulties obtaining supplies.
India has its own vulnerability.
The Indian government said in July 2026 that the country currently imports all of its sintered NdFeB rare-earth permanent magnet requirements, because domestic midstream capacity from oxides to metals, alloys and magnets remains inadequate. India has approved a ?7,280 crore scheme to establish domestic manufacturing capacity.
The government estimates India's rare-earth permanent magnet requirement could reach 8,220 tonnes a year by 2030, including 3,250 tonnes for electric vehicles and 1,800 tonnes for wind turbines.
This is where an enduring US-China accommodation could be useful for India in the short term. Stable Chinese exports would reduce the risk of another sudden supply shock.
But strategically, India's response is already moving in the opposite direction: build domestic capacity and diversify suppliers.
Electronics: opportunity and dependence at the same time
Electronics could become one of the biggest beneficiaries of supply-chain diversification.
India's electronics production reached ?11.32 lakh crore in FY2024-25, according to the Ministry of Electronics and Information Technology. Electronics exports rose to ?3.27 lakh crore from ?2.41 lakh crore the previous year.
That expansion is important because electronics is one of the areas where the US-China relationship has become heavily politicised.
If American companies continue pursuing a China-plus-one strategy, India can offer a large domestic market, an expanding manufacturing base and government-backed incentives.
But India's electronics industry still depends substantially on imported components. China's role is particularly important in areas such as electronic components, machinery and intermediate goods.
So, if Trump and Xi reduce tariffs and technology restrictions, Indian manufacturers could gain from cheaper and more predictable Chinese inputs. At the same time, the relative urgency for global companies to move deeper into India could diminish.
Semiconductors: India's window remains open
The semiconductor sector presents a similar calculation.
India is trying to build a domestic semiconductor ecosystem through the India Semiconductor Mission and related incentives. The stated objective is to establish India as a global hub for electronics manufacturing and design.
The US-China technology competition has strengthened the strategic case for this effort. Washington has restricted access to advanced technologies and AI chips for China, while Beijing has sought to build greater technological self-reliance. The two sides remain competitors even as they attempt to stabilise their broader economic relationship.
For India, this creates an opening to position itself as a trusted manufacturing and technology partner for companies seeking alternatives to China.
A Trump-Xi accommodation would not necessarily close that opportunity. The US and China are still competing in advanced technology, and the technology restrictions and security concerns surrounding AI chips and other strategic technologies remain.
Pharmaceuticals: India has an established advantage
Pharmaceuticals provide another area where India has a structural opportunity.
India is already one of the world's leading pharmaceutical exporters. A government-backed sector study notes that India has a comparative advantage over China in formulations and APIs across several major markets, including the US.
That gives India an opportunity to strengthen its role in global pharmaceutical supply chains as companies seek diversification.
However, China remains important to India's pharmaceutical manufacturing ecosystem because Indian companies source several chemicals and pharmaceutical intermediates from China.
A more stable US-China relationship could therefore reduce input-price volatility for Indian pharmaceutical companies, even while India's long-term objective remains diversification and greater domestic manufacturing of critical inputs.
EVs and defence: rare earths make the China factor unavoidable
Electric vehicles, renewable energy and defence manufacturing all depend on materials in which China has a strong position.
Rare-earth permanent magnets are used in EV motors, wind turbines, electronics, aerospace and defence applications. India's government has explicitly identified these sectors as reasons for developing domestic REPM manufacturing.
For Indian EV and defence manufacturers, predictable Chinese supplies can therefore be beneficial in the near term.
But dependence carries a strategic risk. China's ability to restrict exports means that an India that expands EV production, advanced electronics and defence manufacturing without building alternative mineral and magnet supply chains could remain vulnerable to decisions taken in Beijing.
That is why India's domestic rare-earth programme matters almost as much as the Trump-Xi negotiations themselves.
The biggest question: Will China-plus-one survive a Trump-Xi deal?
This is ultimately the hidden India story.
A US-China agreement could reduce tariffs, improve access to rare earths and make global trade more predictable. That would help India because Indian manufacturers use Chinese inputs and sell products into global markets.
But if the agreement goes much further and restores confidence in China as the dominant manufacturing base, some of the incentive for multinational companies to diversify production could weaken.
India's strongest position therefore comes from a middle path.
It does not need a breakdown in US-China relations to attract investment. It needs to become competitive enough that companies continue to diversify even when China and the US are cooperating.
The numbers show why India has a base to build on. US goods imports from India exceeded $100 billion in 2025, while Indian electronics exports are rising rapidly. At the same time, China's $131.62 billion import relationship with India shows how deeply the Chinese supply chain remains embedded in the Indian economy.
The Trump-Xi summit could therefore produce both gains and challenges for India.
If rare-earth flows stabilise, Indian EV, electronics and defence manufacturers could benefit from more predictable inputs. If tariff tensions ease, global trade could become less disruptive. If US companies maintain supply-chain diversification, India could gain manufacturing investment.
The potential downside is equally clear. A broader US-China economic reset could reduce the pressure on multinational companies to move production away from China.
For India, the strategic opportunity is consequently not to choose between Washington and Beijing. It is to use the competition between the two to accelerate domestic capabilities in electronics, semiconductors, critical minerals, pharmaceuticals, defence manufacturing and advanced technology.
The Trump-Xi meeting may be about managing the US-China relationship. Its longer-term significance for India could be determined by how successfully New Delhi converts that relationship's uncertainty into supply-chain resilience and manufacturing capacity at home.
